Carcinoma origin dictates differential skewing of monocyte function

Area of Science:

• Immunology and Cancer Biology
• Tumor Microenvironment
• Cellular Phenotypic Plasticity

Background:

• Macrophages exhibit diverse functional states, including pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes.
• Tumor-associated macrophages can promote or suppress tumor growth depending on the specific tumor microenvironment.
• Understanding how cancer cells influence macrophage polarization is crucial for developing effective cancer therapies.

Purpose of the Study:

• To investigate the differential effects of breast and colon carcinoma cells on human monocyte polarization.
• To identify key factors secreted by cancer cells that mediate monocyte activation.
• To correlate observed macrophage polarization with patient prognosis in breast and colon carcinomas.

Main Methods:

• Human monocytes were cultured with supernatants from breast and colon carcinoma cell lines.
• Cytokine and chemokine expression profiles were analyzed using techniques like quantitative PCR and ELISA.
• Secretome analysis, including proteoglycan identification (versican), was performed.
• Functional assays involved blocking versican activity with monoclonal antibodies and shRNA.

Main Results:

• Breast cancer supernatants induced monocyte expression of IL-10, IL-8, CCL17, and CCL22, characteristic of an alternatively-activated (M2) phenotype.
• Colon cancer supernatants promoted pro-inflammatory cytokine (IL-12, TNFα) production and reactive oxygen species generation in monocytes, indicative of a classically-activated (M1) phenotype.
• Colon carcinoma cells exclusively secreted the proteoglycan versican, which was found to drive pro-inflammatory monocyte responses.
• Macrophage presence correlates with poor prognosis in breast cancer and good prognosis in colon cancer.

Conclusions:

• Colon and breast cancer cells differentially polarize monocytes, leading to distinct macrophage phenotypes.
• Versican secreted by colon cancer cells plays a role in promoting an anti-tumorigenic M1 macrophage response.
• The distinct macrophage polarization patterns may explain the contrasting clinical outcomes observed in breast and colon cancer patients.
• Targeting monocyte differentiation towards M1-activated tumor macrophages presents a potential therapeutic strategy for cancer treatment.